BFA
AVEO

BlackRock Fund Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

BlackRock Fund Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$9K Buy
1,627
+378
+30% +$2.52K ﹤0.01% 3985
2016
Q3 		$11K Sell
1,249
-1,166
-48% -$11K ﹤0.01% 3957
2016
Q2 		$23K Sell
2,415
-10,734
-82% -$103K ﹤0.01% 3895
2016
Q1 		$121K Sell
13,149
-940
-7% -$9.31K ﹤0.01% 3619
2015
Q4 		$178K Buy
14,089
+604
+4% +$7.18K ﹤0.01% 3575
2015
Q3 		$163K Sell
13,485
-356
-3% -$5.14K ﹤0.01% 3560
2015
Q2 		$241K Sell
13,841
-966
-7% -$17.4K ﹤0.01% 3456
2015
Q1 		$215K Sell
14,807
-1,003
-6% -$11K ﹤0.01% 3464
2014
Q4 		$133K Buy
15,810
+1,129
+8% +$10.3K ﹤0.01% 3571
2014
Q3 		$163K Sell
14,681
-1,066
-7% -$13.6K ﹤0.01% 3538
2014
Q2 		$288K Sell
15,747
-128,030
-89% -$1.67M ﹤0.01% 3357
2014
Q1 		$2.15M Buy
143,777
+1,289
+0.9% +$23.2K ﹤0.01% 3130
2013
Q4 		$2.61M Sell
142,488
-62,904
-31% -$1.26M ﹤0.01% 3098
2013
Q3 		$4.23M Buy
205,392
+36,645
+22% +$839K ﹤0.01% 2915
2013
Q2 		$4.22M Buy
+168,747
New +$7.21M ﹤0.01% 2800

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

BlackRock Fund Advisors's AVEO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its AVEO Pharmaceuticals, Inc. (AVEO) stake by 30% in Q4 2016, buying an estimated $2.52K and bringing the position to 1,627 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #3985.

BlackRock Fund Advisors first reported a position in AVEO in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.23M in Q3 2013. 44 funds tracked by Wall St. Rank hold AVEO as of Q4 2016.

  • BlackRock Fund Advisors held 1,627 shares of AVEO Pharmaceuticals, Inc. worth $9K as of Q4 2016.
  • BlackRock Fund Advisors bought 378 AVEO Pharmaceuticals, Inc. shares in Q4 2016, an estimated $2.52K.
  • AVEO Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3985 holding.
  • BlackRock Fund Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's AVEO Pharmaceuticals, Inc. position peaked at $4.23M in Q3 2013.
  • 44 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.